GAROFALO HEALTH CARE SPA (GHC.MI) Fundamental Analysis & Valuation

BIT:GHC • IT0005345233

Current stock price

4.52 EUR
-0.09 (-1.95%)
Last:

This GHC.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. GHC.MI Profitability Analysis

1.1 Basic Checks

  • GHC had positive earnings in the past year.
  • GHC had a positive operating cash flow in the past year.
  • In the past 5 years GHC has always been profitable.
  • Each year in the past 5 years GHC had a positive operating cash flow.
GHC.MI Yearly Net Income VS EBIT VS OCF VS FCFGHC.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

  • With a decent Return On Assets value of 3.66%, GHC is doing good in the industry, outperforming 70.37% of the companies in the same industry.
  • GHC has a Return On Equity (9.57%) which is in line with its industry peers.
  • The Return On Invested Capital of GHC (6.52%) is better than 77.78% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for GHC is in line with the industry average of 5.91%.
  • The 3 year average ROIC (4.41%) for GHC is below the current ROIC(6.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.66%
ROE 9.57%
ROIC 6.52%
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
GHC.MI Yearly ROA, ROE, ROICGHC.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 4.62%, GHC is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
  • GHC's Profit Margin has declined in the last couple of years.
  • The Operating Margin of GHC (9.37%) is better than 81.48% of its industry peers.
  • GHC's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 44.90%, GHC is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GHC has remained more or less at the same level.
Industry RankSector Rank
OM 9.37%
PM (TTM) 4.62%
GM 44.9%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
GHC.MI Yearly Profit, Operating, Gross MarginsGHC.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. GHC.MI Health Analysis

2.1 Basic Checks

  • GHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for GHC remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for GHC has been increased compared to 5 years ago.
  • GHC has a better debt/assets ratio than last year.
GHC.MI Yearly Shares OutstandingGHC.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
GHC.MI Yearly Total Debt VS Total AssetsGHC.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 1.87 indicates that GHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • GHC's Altman-Z score of 1.87 is in line compared to the rest of the industry. GHC outperforms 59.26% of its industry peers.
  • The Debt to FCF ratio of GHC is 70.49, which is on the high side as it means it would take GHC, 70.49 years of fcf income to pay off all of its debts.
  • GHC's Debt to FCF ratio of 70.49 is on the low side compared to the rest of the industry. GHC is outperformed by 77.78% of its industry peers.
  • GHC has a Debt/Equity ratio of 0.67. This is a neutral value indicating GHC is somewhat dependend on debt financing.
  • GHC has a Debt to Equity ratio of 0.67. This is in the better half of the industry: GHC outperforms 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 70.49
Altman-Z 1.87
ROIC/WACC1.04
WACC6.25%
GHC.MI Yearly LT Debt VS Equity VS FCFGHC.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

  • GHC has a Current Ratio of 1.16. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
  • GHC has a Current ratio of 1.16. This is in the better half of the industry: GHC outperforms 62.96% of its industry peers.
  • A Quick Ratio of 1.12 indicates that GHC should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.12, GHC is doing good in the industry, outperforming 70.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.12
GHC.MI Yearly Current Assets VS Current LiabilitesGHC.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. GHC.MI Growth Analysis

3.1 Past

  • The earnings per share for GHC have decreased strongly by -12.11% in the last year.
  • GHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.81% yearly.
  • The Revenue has grown by 10.44% in the past year. This is quite good.
  • GHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.92% yearly.
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.47% on average over the next years.
  • GHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.51% yearly.
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GHC.MI Yearly Revenue VS EstimatesGHC.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
GHC.MI Yearly EPS VS EstimatesGHC.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

4

4. GHC.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 12.56, the valuation of GHC can be described as correct.
  • Based on the Price/Earnings ratio, GHC is valued a bit cheaper than the industry average as 74.07% of the companies are valued more expensively.
  • GHC is valuated cheaply when we compare the Price/Earnings ratio to 25.61, which is the current average of the S&P500 Index.
  • GHC is valuated correctly with a Price/Forward Earnings ratio of 13.99.
  • GHC's Price/Forward Earnings is on the same level as the industry average.
  • GHC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.56
Fwd PE 13.99
GHC.MI Price Earnings VS Forward Price EarningsGHC.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • GHC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GHC is cheaper than 81.48% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, GHC is valued a bit more expensive than 77.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 125.52
EV/EBITDA 6.56
GHC.MI Per share dataGHC.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • GHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.64
PEG (5Y)1.42
EPS Next 2Y5.05%
EPS Next 3Y6.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. GHC.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.07%, GHC has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.96, GHC has a dividend in line with its industry peers.
  • GHC's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 2.07%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y5.05%
EPS Next 3Y6.47%
GHC.MI Yearly Income VS Free CF VS DividendGHC.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

Find the best dividend stocksShow peers with best dividend

GHC.MI Fundamentals: All Metrics, Ratios and Statistics

GAROFALO HEALTH CARE SPA

BIT:GHC (3/25/2026, 5:29:46 PM)

4.52

-0.09 (-1.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-14
Earnings (Next)N/A
Inst Owners10.79%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap407.70M
Revenue(TTM)690.85M
Net Income(TTM)31.91M
Analysts84
Price Target6.73 (48.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.07%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 12.56
Fwd PE 13.99
P/S 0.59
P/FCF 125.52
P/OCF 14.59
P/B 1.22
P/tB N/A
EV/EBITDA 6.56
EPS(TTM)0.36
EY7.96%
EPS(NY)0.32
Fwd EY7.15%
FCF(TTM)0.04
FCFY0.8%
OCF(TTM)0.31
OCFY6.85%
SpS7.66
BVpS3.7
TBVpS-0.44
PEG (NY)3.64
PEG (5Y)1.42
Graham Number5.47
Profitability
Industry RankSector Rank
ROA 3.66%
ROE 9.57%
ROCE 9.13%
ROIC 6.52%
ROICexc 6.77%
ROICexgc 14.86%
OM 9.37%
PM (TTM) 4.62%
GM 44.9%
FCFM 0.47%
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
ROICexc(3y)4.63%
ROICexc(5y)4.13%
ROICexgc(3y)10.78%
ROICexgc(5y)9.37%
ROCE(3y)6.5%
ROCE(5y)5.8%
ROICexgc growth 3Y7.97%
ROICexgc growth 5Y2.8%
ROICexc growth 3Y6.71%
ROICexc growth 5Y0.74%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 70.49
Debt/EBITDA 2.47
Cap/Depr 94.13%
Cap/Sales 3.57%
Interest Coverage 6.62
Cash Conversion 30.7%
Profit Quality 10.18%
Current Ratio 1.16
Quick Ratio 1.12
Altman-Z 1.87
F-Score5
WACC6.25%
ROIC/WACC1.04
Cap/Depr(3y)82.25%
Cap/Depr(5y)102.09%
Cap/Sales(3y)4.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)118.21%
Profit Quality(5y)101.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
EBIT growth 1Y-8.88%
EBIT growth 3Y18.26%
EBIT growth 5Y14.91%
EBIT Next Year68.09%
EBIT Next 3Y22.98%
EBIT Next 5Y16.09%
FCF growth 1Y-88.34%
FCF growth 3Y4.79%
FCF growth 5Y6.69%
OCF growth 1Y-35.2%
OCF growth 3Y-1.23%
OCF growth 5Y13.09%

GAROFALO HEALTH CARE SPA / GHC.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GAROFALO HEALTH CARE SPA (GHC.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to GHC.MI.


What is the valuation status for GHC stock?

ChartMill assigns a valuation rating of 4 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Fairly Valued.


How profitable is GAROFALO HEALTH CARE SPA (GHC.MI) stock?

GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 6 / 10.


What is the financial health of GAROFALO HEALTH CARE SPA (GHC.MI) stock?

The financial health rating of GAROFALO HEALTH CARE SPA (GHC.MI) is 4 / 10.


What is the expected EPS growth for GAROFALO HEALTH CARE SPA (GHC.MI) stock?

The Earnings per Share (EPS) of GAROFALO HEALTH CARE SPA (GHC.MI) is expected to grow by 3.45% in the next year.